Identification and validation of DOCK4 as a potential biomarker for risk of bone metastasis development in patients with early breast cancer.

J Pathol · 2019 · PMC6618075 · PMID 30426503

Europe PMC DOI

hedged sentence

0.0620

closest p · 1.2× alpha

0.0620

boldest claim

The sentences

approached significancep = 0.062so close (0.05 < p ≤ 0.1)

DOCK4 had no significant associations with age, lymph node involvement, ER status, tumour grade (although this approached significance, p = 0.062), menopausal status, systemic therapy, chemotherapy and statin use.

also in 8,237 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.